Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 32 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation functionBuchanan, G.; Yang, M.; Harris, J.; Nahm, H.; Han, G.; Moore, N.; Bentel, J.; Matusik, R.; Horsfall, D.; Marshall, V.; Greenberg, N.; Tilley, W.
2006Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variantButler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
2001Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylaseButler, L.; Webb, Y.; Agus, D.; Higgins, B.; Tolentino, T.; Kutko, M.; LaQuaglia, M.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H.; Breslow, R.; Richon, V.; Rifkind, R.; Marks, P.
2001Collocation of androgen receptor gene mutations in prostate cancerBuchanan, G.; Greenberg, N.; Scher, H.; Harris, J.; Marshall, V.; Tilley, W.
2007Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motilityRicciardelli, C.; Russell, D.; Ween, M.; Mayne, K.; Suwiwat, S.; Byers, S.; Marshall, V.; Tilley, W.; Horsfall, D.
2007Androgen receptor coregulators and their involvement in the development and progression of prostate cancerChmelar, R.; Buchanan, G.; Need, E.; Tilley, W.; Greenberg, N.
2009Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cellsBacker, J.; Krivoshein, A.; Hamby, C.; Pizzonia, J.; Gilbert, K.; Ray, Y.; Brand, H.; Paton, A.; Paton, J.; Backer, M.
2020Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletionKohno, S.; Linn, P.; Nagatani, N.; Watanabe, Y.; Kumar, S.; Soga, T.; Takahashi, C.
2019Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancerWatt, M.J.; Clark, A.K.; Selth, L.A.; Haynes, V.R.; Lister, N.; Rebello, R.; Porter, L.H.; Niranjan, B.; Whitby, S.T.; Lo, J.; Huang, C.; Schittenhelm, R.B.; Anderson, K.E.; Furic, L.; Wijayaratne, P.R.; Matzaris, M.; Montgomery, M.K.; Papargiris, M.; Norden, S.; Febbraio, M.; et al.
2017Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancerPaltoglou, S.; Das, R.; Townley, S.; Hickey, T.; Tarulli, G.; Coutinho, I.; Fernandes, R.; Hanson, A.; Denis, I.; Carroll, J.; Dehm, S.; Raj, G.; Plymate, S.; Tilley, W.; Selth, L.